These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22945509)

  • 1. Molecular diagnosis of minimal residual disease in head and neck cancer patients.
    Graveland AP; Braakhuis BJ; Eerenstein SE; de Bree R; Bloemena E; de Maaker M; van den Brekel MW; Dijk F; Mesker WE; Tanke HJ; Leemans CR; Brakenhoff RH
    Cell Oncol (Dordr); 2012 Oct; 35(5):367-75. PubMed ID: 22945509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular detection of minimal residual cancer in surgical margins of head and neck cancer patients.
    Graveland AP; de Maaker M; Braakhuis BJ; de Bree R; Eerenstein SE; Bloemena E; Leemans CR; Brakenhoff RH
    Cell Oncol; 2009; 31(4):317-28. PubMed ID: 19633367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reaction in bone marrow of head and neck cancer patients.
    Colnot DR; Nieuwenhuis EJ; Kuik DJ; Leemans CR; Dijkstra J; Snow GB; van Dongen GA; Brakenhoff RH
    Clin Cancer Res; 2004 Dec; 10(23):7827-33. PubMed ID: 15585614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of gene methylation in surgical margin imprints with locoregional recurrence in head and neck squamous cell carcinoma.
    Hayashi M; Wu G; Roh JL; Chang X; Li X; Ahn J; Goldsmith M; Khan Z; Bishop J; Zhang Z; Zhou XC; Richmon J; Agrawal N; Koch WM
    Cancer; 2015 Jun; 121(12):1957-65. PubMed ID: 25773145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of molecular alterations in histologically negative surgical margins of head and neck cancer patients.
    de Carvalho AC; Kowalski LP; Campos AH; Soares FA; Carvalho AL; Vettore AL
    Oral Oncol; 2012 Mar; 48(3):240-8. PubMed ID: 22104250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study.
    van Houten VM; Leemans CR; Kummer JA; Dijkstra J; Kuik DJ; van den Brekel MW; Snow GB; Brakenhoff RH
    Clin Cancer Res; 2004 Jun; 10(11):3614-20. PubMed ID: 15173067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Cell-Free SEPT9 DNA Methylation in Blood Is a Biomarker for Minimal Residual Disease Detection in Head and Neck Squamous Cell Carcinoma Patients.
    Dietrich D; Weider S; de Vos L; Vogt TJ; Färber M; Zarbl R; Hunecke A; Glosch AK; Gabrielpillai J; Bootz F; Bauernfeind FG; Kramer FJ; Kristiansen G; Brossart P; Strieth S; Franzen A
    Clin Chem; 2023 Sep; 69(9):1050-1061. PubMed ID: 37477541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular diagnosis of head and neck cancer.
    van Houten VM; van den Brekel MW; Denkers F; Colnot DR; Westerga J; van Diest PJ; Snow GB; Brakenhoff RH
    Recent Results Cancer Res; 2000; 157():90-106. PubMed ID: 10857164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative molecular detection of minimal residual head and neck cancer in lymph node aspirates.
    Nieuwenhuis EJ; Jaspars LH; Castelijns JA; Bakker B; Wishaupt RG; Denkers F; Leemans CR; Snow GB; Brakenhoff RH
    Clin Cancer Res; 2003 Feb; 9(2):755-61. PubMed ID: 12576446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue imprint for molecular mapping of deep surgical margins in patients with head and neck squamous cell carcinoma.
    Roh JL; Westra WH; Califano JA; Sidransky D; Koch WM
    Head Neck; 2012 Nov; 34(11):1529-36. PubMed ID: 22223471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer.
    van Houten VM; Tabor MP; van den Brekel MW; Kummer JA; Denkers F; Dijkstra J; Leemans R; van der Waal I; Snow GB; Brakenhoff RH
    J Pathol; 2002 Dec; 198(4):476-86. PubMed ID: 12434417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational study.
    Falck AK; Bendahl PO; Ingvar C; Isola J; Jönsson PE; Lindblom P; Lövgren K; Rennstam K; Fernö M; Rydén L
    BMC Cancer; 2012 Sep; 12():403. PubMed ID: 22963449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical detection of lymph node-DTCs in patients with node-negative HNSCC.
    Sproll C; Freund AK; Hassel A; Hölbling M; Aust V; Storb SH; Handschel J; Teichmann C; Depprich R; Behrens B; Neves RP; Kübler NR; Kaiser P; Baldus SE; Tóth C; Kaisers W; Stoecklein NH
    Int J Cancer; 2017 May; 140(9):2112-2124. PubMed ID: 28120418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paired box 5 methylation detection by droplet digital PCR for ultra-sensitive deep surgical margins analysis of head and neck squamous cell carcinoma.
    Hayashi M; Guerrero-Preston R; Sidransky D; Koch WM
    Cancer Prev Res (Phila); 2015 Nov; 8(11):1017-26. PubMed ID: 26304463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive frozen section margins predict local recurrence in R0-resected squamous cell carcinoma of the head and neck.
    Ettl T; El-Gindi A; Hautmann M; Gosau M; Weber F; Rohrmeier C; Gerken M; Müller S; Reichert T; Klingelhöffer C
    Oral Oncol; 2016 Apr; 55():17-23. PubMed ID: 27016013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high-risk 70-gene signature is not associated with the detection of tumor cell dissemination to the bone marrow.
    Walter VP; Taran FA; Wallwiener M; Walter C; Grischke EM; Wallwiener D; Brucker SY; Hartkopf AD
    Breast Cancer Res Treat; 2018 Jun; 169(2):305-309. PubMed ID: 29374853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment.
    Partridge M; Li SR; Pateromichelakis S; Francis R; Phillips E; Huang XH; Tesfa-Selase F; Langdon JD
    Clin Cancer Res; 2000 Jul; 6(7):2718-25. PubMed ID: 10914716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck.
    Brennan JA; Mao L; Hruban RH; Boyle JO; Eby YJ; Koch WM; Goodman SN; Sidransky D
    N Engl J Med; 1995 Feb; 332(7):429-35. PubMed ID: 7619114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual nodal disease in patients with advanced-stage oropharyngeal squamous cell carcinoma treated with definitive radiation therapy and posttreatment neck dissection: Association with locoregional recurrence, distant metastasis, and decreased survival.
    Sandulache VC; Ow TJ; Daram SP; Hamilton J; Skinner H; Bell D; Rosenthal DI; Beadle BM; Ang KK; Kies MS; Johnson FM; El-Naggar AK; Myers JN
    Head Neck; 2013 Oct; 35(10):1454-60. PubMed ID: 23018868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance of circulating tumour cells in the bone marrow of patients with SCCHN.
    Wollenberg B; Walz A; Kolbow K; Pauli C; Chaubal S; Andratschke M
    Onkologie; 2004 Aug; 27(4):358-62. PubMed ID: 15347890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.